{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:09:43Z","timestamp":1792282183925,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T00:00:00Z","timestamp":1298246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00066-010-2227-x","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T16:50:22Z","timestamp":1298393422000},"page":"158-166","source":"Crossref","is-referenced-by-count":20,"title":["Interdisciplinary Evidence-Based Recommendations for the Follow-Up of Early Stage Seminomatous Testicular Germ Cell Cancer Patients","Interdisziplin\u00e4re evidenzbasierte Empfehlungen f\u00fcr die Nachbeobachtung von Patienten mit testikul\u00e4rem Seminom im Fr\u00fchstadium"],"prefix":"10.1007","volume":"187","author":[{"given":"Rainer","family":"Souchon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Krege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Gillessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,21]]},"reference":[{"key":"2227_CR1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.eururo.2005.06.019","volume":"48","author":"Albers","year":"2005","unstructured":"Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer. EAU European Association of Urology 2009. Eur Urol 2005;48:885\u201394.","journal-title":"Eur Urol"},{"key":"2227_CR2","unstructured":"American Society of Clinical Oncology Guideline Procedures Manual (De-cember 2006). Expert Panel Version 2.0. Alexandria, VA: ASCO (http:\/\/www.asco.org)."},{"key":"2227_CR3","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/archinternmed.2009.440","volume":"169","author":"Berrington de Gonzalez","year":"2009","unstructured":"Berrington de Gonzalez A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009;169:2071\u20137.","journal-title":"Arch Intern Med"},{"key":"2227_CR4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.2323031095","volume":"232","author":"Brenner","year":"2004","unstructured":"Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004;232:735\u20138.","journal-title":"Radiology"},{"key":"2227_CR5","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","volume":"357","author":"Brenner","year":"2007","unstructured":"Brenner DJ, Hall EJ. Computed tomography \u2013 an increasing source of radiation exposure. N Engl J Med 2007;357:2277\u201384.","journal-title":"N Engl J Med"},{"key":"2227_CR6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1200\/JCO.2005.05.4791","volume":"25","author":"Carver","year":"2007","unstructured":"Carver BS, Shayegan B, Serio A, et al. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 2007;25:1033\u20137.","journal-title":"J Clin Oncol"},{"key":"2227_CR7","first-page":"356","volume":"140","author":"Cathomas","year":"2010","unstructured":"Cathomas R, Helbling D, Stenner F, et al. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkl 2010;140:356\u201369.","journal-title":"Swiss Med Wkl"},{"key":"2227_CR8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1200\/JCO.2003.06.065","volume":"21","author":"Cla\u00dfen","year":"2003","unstructured":"Cla\u00dfen J, Schmidberger H, Meisner C, et al. Radiotherapy for stage IIA\/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 2003;21:1101\u20136.","journal-title":"J Clin Oncol"},{"key":"2227_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00066-009-1958-z","volume":"185","author":"Classen","year":"2009","unstructured":"Classen J, Schmidberger H, Souchon R, et al. What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy? Strahlenther Onkol 2009;185:349\u201354.","journal-title":"Strahlenther Onkol"},{"key":"2227_CR10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00066-009-1958-z","volume":"185","author":"Classen","year":"2009","unstructured":"Classen J. Radiotherapie oder Chemotherapie beim reinen Seminom im Stadium IIA und IIB? Strahlenther Onkol 2009;185:611\u20133.","journal-title":"Strahlenther Onkol"},{"key":"2227_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00432-009-0653-x","volume":"136","author":"Classen","year":"2010","unstructured":"Classen J, Souchon R, Hehr T, et al. Posttreatment surveillance after paraaortic radiotherapy for stage I seminoma: a systematic analysis. J Cancer Res Clin Oncol 2010;136:227\u201332.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2227_CR12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1102\/1470-7330.2006.0020","volume":"6","author":"Dalal","year":"2006","unstructured":"Dalal PU, Sohaib, SA, Huddart R. Imaging of testicular germ cell tumors. Cancer Imaging 2006;6:124\u201334.","journal-title":"Cancer Imaging"},{"key":"2227_CR13","first-page":"139","volume":"137","author":"Damgaard-Pedersen","year":"1991","unstructured":"Damgaard-Pedersen K, von der Maase H. Ultrasound and ultrasound guided biopsy, CT and lymphography in the diagnosis of retroperitoneal metastases in testicular cancer. Scand J Urol Nephrol Suppl. 1991;137:139\u201344.","journal-title":"Scand J Urol Nephrol"},{"key":"2227_CR14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","volume":"22","author":"De Santis","year":"2004","unstructured":"De Santis M, Becherer A, Bokemeyer C, et al. 2-18fluorodeoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 2004;22:1034\u20139.","journal-title":"J Clin Oncol"},{"key":"2227_CR15","doi-asserted-by":"crossref","unstructured":"De Santis M, Strau G, and Bachner M. Cross-sectional imaging techniques: the use of computed tomography (CT) and magnetic resonance imaging (MRI) in the management of germ cell tumors. In: de la Rosette JMCH, Manyak MJ, Harisinghani MG, Wijkstra H (eds) Imaging in Oncological Urology. Springer Verlag, Berlin 2009, chapter 27, 287.","DOI":"10.1007\/978-1-84628-759-6_27"},{"key":"2227_CR16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(05)68561-8","volume":"162","author":"Dieckmann","year":"1999","unstructured":"Dieckmann KP, Souchon R, Hahn E, et al. False-negative biopsies for testicular intraepithelial neoplasia. J Urol 1999;162:364\u20138.","journal-title":"J Urol"},{"key":"2227_CR17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0302-2838(02)00047-7","volume":"41","author":"Dieckmann","year":"2002","unstructured":"Dieckmann KP, Lauke H, Michl U, et al. Testicular germ cell cancer despite previous local radiotherapy to the testis. Eur Urol 2002;41:643\u20139.","journal-title":"Eur Urol"},{"key":"2227_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-009-1937-4","volume":"185","author":"Eich","year":"2009","unstructured":"Eich HT. Langzeitnebenwirkungen nach Hochdosis-Chemotherapie und Radiotherapie bei Patienten mit rezidivierten oder refrakt\u00e4ren Hodgkin-Lymphomen. Strahlenther Onkol 2009;185:541\u20132.","journal-title":"Strahlenther Onkol"},{"key":"2227_CR19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/02841860310023174","volume":"43","author":"Fossa","year":"2004","unstructured":"Fossa SD. Long-term sequelae after cancer therapy \u2013 survivorship after treatment for testicular cancer. Acta Oncol 2004;43:134\u201341.","journal-title":"Acta Oncol"},{"key":"2227_CR20","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.2009.26.4481","volume":"28","author":"Gilligan","year":"2010","unstructured":"Gilligan TD, Seidenfeld J, Basch EM et al.; American Society of Clinical Oncology. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 2010;28:3388\u2013404.","journal-title":"J Clin Oncol"},{"key":"2227_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/annonc\/mdf032","volume":"13","author":"Harvey","year":"2002","unstructured":"Harvey ML, Geldart TR, Duell R, et al. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer \u2013 a necessary risk? Ann Oncol 2002;13:237\u201342.","journal-title":"Ann Oncol"},{"key":"2227_CR22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11764-008-0054-1","volume":"2","author":"Haugnes","year":"2008","unstructured":"Haugnes HS, Aass N, Fossa SD, et al. Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. J Cancer Surviv 2008;2:128\u201337.","journal-title":"J Cancer Surviv"},{"key":"2227_CR23","doi-asserted-by":"crossref","unstructured":"International Germ Cell Cancer Collaborative Group (IGCCCG). The International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancer. J Clin Oncol 1997;15: 594\u2013603.","DOI":"10.1200\/JCO.1997.15.2.594"},{"key":"2227_CR24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2007.12.024","volume":"53","author":"Krege","year":"2008","unstructured":"Krege S, Beyer J, Souchon R, et al. European Consensus Conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG). Part I and II. Eur Urol 2008;53:478\u201396 and 497\u2013513.","journal-title":"Eur Urol"},{"key":"2227_CR25","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/cncr.22674","volume":"109","author":"Martin","year":"2007","unstructured":"Martin JM, Panzarella T, Zwahlen DR, et al. Evidence-based guidelines for following stage 1 seminoma. Cancer 2007;109:2248\u201356.","journal-title":"Cancer"},{"key":"2227_CR26","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1200\/JCO.2008.17.6198","volume":"26","author":"Mead","year":"2008","unstructured":"Mead GM, Fossa SD, Oliver RT, et al. Relapse patterns in 2.466 stage I semi-noma patients entered into Medical Research Council randomised trials. J Clin Oncol 2008;26(suppl):5020.","journal-title":"J Clin Oncol"},{"key":"2227_CR27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000099342","volume":"78","author":"Mezvrishvili","year":"2007","unstructured":"Mezvrishvili Z, Tchanturaia Z, Toidze T, et al. Is ultrasound of the retroperitoneum a valuable staging method in selecting testicular cancer patients for primary retroperitoneal lymph node dissection? Urol Int 2007;78:226\u20139.","journal-title":"Urol Int"},{"key":"2227_CR28","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1200\/JCO.2005.02.176","volume":"23","author":"Nuver","year":"2005","unstructured":"Nuver J, Smit AJ, Wolffenbuttel BHR, et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005;23:3718\u201325.","journal-title":"J Clin Oncol"},{"key":"2227_CR29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/annonc\/mdh301","volume":"15","author":"Schmoll","year":"2004","unstructured":"Schmoll HJ, Souchon R, Krege S, et al. European Consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377\u201399.","journal-title":"Ann Oncol"},{"key":"2227_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdq176","volume":"21","author":"Schmoll","year":"2010","unstructured":"Schmoll HJ, Jordan K, Huddart R, et al. Testicular seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow up. Ann Oncol 2010;21(Suppl 5):140\u20136.","journal-title":"Ann Oncol 2010"},{"key":"2227_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/annonc\/mdq177","volume":"21","author":"Schmoll","year":"2010","unstructured":"Schmoll HJ, Jordan K, Huddart R, et al. Testicular non-seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow. Ann Oncol 2010;21(Suppl 5):147\u201354.","journal-title":"Ann Oncol"},{"key":"2227_CR32","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1200\/JCO.2009.23.9608","volume":"28","author":"Shinn","year":"2010","unstructured":"Shinn EH, Swartz RJ, Thornton BB, et al. Testis cancer survivors\u2019 health behaviors: comparison with age-matched relative and demographically matched population controls. J Clin Oncol 2010;28:2274\u20139.","journal-title":"J Clin Oncol"},{"key":"2227_CR33","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/archinternmed.2009.427","volume":"169","author":"Smith-Bindman","year":"2009","unstructured":"Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated attributable risk of cancer. Arch Intern Med 2009;169:2078\u201386.","journal-title":"Arch Intern Med"},{"key":"2227_CR34","unstructured":"Souchon R, Schmoll HJ, Krege S, Heidenreich A. Leitlinie zur Diagnostik und Therapie von Hodentumoren auf Grundlage evidenzbasierter Medizin: German Testicular Cancer Study Group. Zuckschwerdt Verlag 2002."},{"key":"2227_CR35","unstructured":"Testicular Cancer. NCCN National Comprehensive Cancer Network, version 2007 (http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp)."},{"key":"2227_CR36","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40.576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005;97:1354\u201365.","journal-title":"J Natl Cancer Inst"},{"key":"2227_CR37","unstructured":"TRISST (MRC TE24) Trial of imaging and schedule in seminoma testis (http:\/\/www.ctu.mrc.ac.uk\/studies\/TE24.asp)."},{"key":"2227_CR38","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/sj.bjc.6604280","volume":"98","author":"As van","year":"2008","unstructured":"van As NJ, Gilbert DC, Money-Kyrle J, et al. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer 2008;98:1894\u2013902.","journal-title":"Br J Cancer"},{"key":"2227_CR39","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","volume":"25","author":"Belt-Dusebout Van den","year":"2007","unstructured":"Van den Belt-Dusebout A, de Wit R, Gietema JA, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370\u20138.","journal-title":"J Clin Oncol"},{"key":"2227_CR40","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002;20:4448\u201352.","journal-title":"J Clin Oncol"},{"key":"2227_CR41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0009-9260(97)80105-5","volume":"52","author":"White","year":"1997","unstructured":"White PM, Howard GCW, Best JJK, Wright AR. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumors. Clin Radiol 1997;52:124\u20139.","journal-title":"Clin Radiol"},{"key":"2227_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00066-009-1003-2","volume":"185","author":"Willich","year":"2009","unstructured":"Willich N, Ernst I, Pape H, et al. Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach. Strahlenther Onkol 2009;185(Suppl 2):3\u20134.","journal-title":"Strahlenther Onkol"},{"key":"2227_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5489\/cuaj.815","volume":"4","author":"Wood","year":"2010","unstructured":"Wood L, Kollmannsberger C, Jewett M, et al. Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J 2010;4:E19\u201338.","journal-title":"Can Urol Assoc J"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2227-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2227-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T15:19:30Z","timestamp":1560007170000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2227-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,21]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2227-x","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,21]]}}}